Research Fellow William J. Watkins, Jr. appeared on Larry Conners USA on KTRS radio, to talk about US Supreme Court Justice Antonin Scalia and his impact on the Supreme Court and the US Constitution. A strict constitutionalist, Scalia rejected the idea that the Constitution is a living, breathing document. Watkins offers his unique perspective on Antonin Scalia and his legacy for America. Watkins also talks about the future of the court and how and when a replacement for Scalia might be chosen. He says Our Constitution is more in jeopardy than it has been for a long time.
Presidential candidate Donald Trump and the New York Times have recently demonized China for its relationship with Iran, but Sr. Fellow Ivan Eland cautions against such rhetoric. Economically, China is not much of a threat, says Eland. Chinas thirst for oil might actually help drive down the price of oil. Criticizing China for human rights violations usually leads to a backlash that harms dissidents. Chinas territorial claims in the South China Seas are too far away for the US to be concerned about, says Eland. China is often seen as the evil enemy some politicians in the US need to appear as if they are strong candidates.
Ivan Eland, Senior Fellow of the Independent Institute, is interviewed by TRT World about the tension between Saudi Arabia and Iran following the execution of Sheikh Nimr al-Nimr by the Saudi Arabian government.
Research Fellow Abigail R. Hall recently wrote an Op-Ed in Forbes about the solution to the growing need for organ transplants: allowing the sale of human organs. Hall rebuts critics who say only poor people would sell their organs, or the practice is morally objectionable. On the contrary, she says. By legalizing the sale of organs, thousands of lives could be saved and desperate, long waits for organ donations would ease.
What is the cost of the long approval process for potentially life-saving drugs by the FDA? The approval process can take up to 12 years and cost $1 billion. But there are other costs. Patients arent able to take drugs that arent approved and they might die or become more ill. Another cost is that a potential drug maker might not want to take the financial risk of taking a drug to market. Powell recommends testing drugs but possibly making drugs "FDA recommended", rather than "FDA approved." Whats needed is competition and markets to help patients and entrepreneurs, says Powell.
Senior Fellow John C. Goodman, author of A Better Choice
is interviewed about Texas Congressman Pete Sessions proposed alternative to Obamacare. Its legislation that will fix problems with the healthcare system that the Affordable Care Act failed to do. Instead of subsidies, everyoneregardless of incomewill be treated equally. Under the proposed plan, which Goodman is helping to craft, the healthcare marketplace will be utilized to lower costs to consumers, with government playing a minimal role.
Senior Fellow Ivan Eland is interviewed on CCTV America about security measures taken by the French Government during the COP21 Climate Change Summit in Paris. After terrorist attacks, France has reinforced borders, mobilized 120,000 police officers, and banned large marches that had been planned to coincide with the climate summit.